
Tag: Carboplatin

Double-positive results for triple-negative metastatic breast cancer
Pembrolizumab prolongs survival in persistent, recurrent, or metastatic cervical cancer
Pembrolizumab shows potential in TKI-resistant EGFR+ NSCLC, not ALK+
Adjuvant chemotherapy does not improve outcome in patients with locally advanced cervical cancer
Platinum-based adjuvant chemotherapy in TNBC is not superior or non-inferior to capecitabine
Perioperative chemotherapy and neoadjuvant multimodality therapy appear equally effective
No higher pathologic complete response with atezolizumab added to chemotherapy
Combination of PARP inhibition plus chemotherapy in ovarian cancer

Longer OS with atezolizumab + carboplatin + nab-paclitaxel in advanced squamous NSCLC
Overcoming the challenges of immunotherapy in non–small cell lung cancer
Other I-O combinations
